All Type of News
Public hearing on 6 year pharmacy system resumed.
The public hearing on the subject of the 6 year pharmacy school system was resumed after the temporary suspension caused by the KMA strikes.
Assistant vice minister Seo Soo-nam of the Ministry Of Education and Huma...
Korea Astellas Pharm. to open cyber training program.
Korea Astellas pharmaceutical company opened an on-line cyber educational program (www.asedu.co.kr) with motion pictures for the medical representatives (MR).
They said that the program provided knowledges and us...
Choongwae to launch a new drug for anti-cholesterol markets.
Choongwae launched Rivaro tablet, a new anti-cholesterol drug (Pitavastatin) on July 1, which was jointly developed by Japanese Kowa and Nissan Chemical having excellent efficacy and safety profiles.
According to t...
Drug industry to explore various strategies for their sales targets.
Most of local pharmaceutical companies are trying to achieve their sales targets during the 2nd half of this year by implementing diverse strategies with product lines, worrying that the sales slow during the first ha...
HIRA to associate with 3 medical societies.
The Health Insurance Review Agency (HIRA) agreed to cooperate about research and survey and share the disease statistics with the Korean Hip Society, the Korean Association for the study of intestinal diseases and the...
Daewoong to suggest new wholesale policy this week.
Before the end of this week Daewoong announced to show the company official position about the new wholesale policy, over which Daewoong mulled in the sales meeting on Saturday and Sunday along.
The new policy will...
Chinese National Development Commissioners to visit KPA
9 members from the Chinese National Development Planning Commission visited the Korea Pharmaceutical Association (KPA) on June 30 to observe the national health insurance system and the medical and pharmacy role separ...
Il Yang pledged new drug R&D push in 59th anniversary ceremony.
Il Yang celebrated the 59th anniversary at the company auditorium at Dokok-dong, Seoul on July 1, declaring far earlier commercialization of the new drug R&D.
Chairman Chung Do-eon said "Given just one year to mee...
Zuellig to cancel Cialis margin rate down.
Zuellig and Lilly Korea agreed to withdraw the lower margin rate policy on Cialis and notified it to all member wholesalers in the metropolitan areas and Busan and Gyeong-nam area who raised harsh challenges against Z...
KFDA to reinforce control for clinical test institutes.
The KFDA announced "Optimizing plan for the inspection of clinical test institutes" in order that the clinical study institutes would be more scrutinized.
The Drug Review Division and the Drug Safety Bureau of KF...
